Path to IND for biologics: Go from DNA to drug product in as few as 9 months
Path to IND for biologics: Go from DNA to drug product in as few as 9 months
See how Path to IND for biologics can save time while maintaining quality. Learn the key steps that compress timelines, including the use of our CHO K1 cell line with transposase technology.

Added Date:

2025-11-24

Filters:

Filter Category Filter Values
Specialty
  • Clinical manufacturing
  • Technical transfer
Month
  • November
Capability
  • Biologics
Year
  • 2025
Language
  • Korean
Asset Type
  • Infographic
Country
  • Korea
Region
  • Asia Pacific (APAC)
Market Category
  • Large molecule
Content Category
  • Collateral

Country Availability:


()

Gated Form:

None Set